Morgan Stanley downgraded Daicel (DACHF) to Equal Weight from Overweight with a price target of 1,400 yen, down from 2,300 yen. The firm expects the fiscal year to start with Q1 profits falling 26% on an unanticipated hit from the moving average for raw material costs, the analyst tells investors.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DACHF:
- Daicel Corporation Corrects Financial Results for FY 2025
- Daicel Corporation Corrects Financial Results for FY 2024
- Daicel Corporation Proposes Amendments to Enhance Business Alignment and Management Flexibility
- Daicel Corporation Announces Cancellation of 10 Million Treasury Shares
- Daicel Corporation Reports Increased Sales but Declining Profits for FY2025